Last month I was fortunate enough to serve on the “Leadership in Public Service” panel during annual presentations for Harvard Business School Reunions. I shared the stage with several incredible Harvard grads who have done great things since leaving school. Below is a brief recap of the day’s events.
Panel – Joining and Serving on Boards
Moderator: Howard Brod Brownstein (JD/MBA 1975), President, The Brownstein Corporation
- Lana Lewin (MBA 1995), Treasurer, Planned Parenthood of New York City; Managing Director, Crédit Suisse
- John T. Mapes (MBA 1995), Managing Partner, Aurora Capital Group
- John F. Ryan IV (MBA 2000), Managing Director, ONSET Ventures
- Eric C. Salzman (MBA 1995), Managing Partner, SarniHaan Capital Partners LLC
Corporate governance is increasingly in the news, including – all too often – the lack thereof. At the same time, serving on boards, both for-profit and nonprofit, is a growing career ambition for many HBS graduates. This panel of accomplished HBS alumni will share their experiences regarding joining and serving on boards and will provide valuable advice about how to join boards and what to expect when one gets there.
Panel – Leadership in Public Service
Moderator: Mitchell B. Weiss, Senior Lecturer of Business Administration, HBS; formerly Chief of Staff to Boston’s Mayor Thomas Menino
- Aaron Chadbourne (MBA 2011), Senior Policy Advisor, Governor Paul LePage, Maine
- Mina Hsiang (MBA 2010), Health Data Expert, US Digital Service at the White House
- Jason Lewis (MBA 1995), State Senator, Commonwealth of Massachusetts
- Ryan Mackenzie (MBA 2010), Member and Deputy Majority Whip, Pennsylvania House of Representatives, Commonwealth of Pennsylvania.
David Linn (MBA 2000), Principal/Cofounder, Oak Point Partners/Cycle for Survival
Cycle for Survival is the national movement to beat rare cancers. Linn founded the high-energy indoor team cycling events in 2007 with his late wife, Jen Goodman Linn (MBA 1999). Cycle for Survival is now the fastest-growing athletic fundraiser in the country with more than $75 million raised for cancer research.